This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jan;26(1):283-4.

doi: 10.1007/s00464-011-1864-1.

Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma

Jannis Kountouras, Dimitrios Chatzopoulos, Christos Zavos, Georgia Deretzi, Stergios A Polyzos, Emmanuel Gavalas, Philippos Klonizakis, Elizabeth Vardaka, Panagiotis Katsinelos, Christos Stergiopoulos, John Moschos, Evaggelia Giartza-Taxidou

PMID: 21858571
DOI: 10.1007/s00464-011-1864-1

Comment

Ki-67 and Bax expression in esophageal mucosa might have implications in ablative therapies for Barrett's esophagus, dysplasia, and adenocarcinoma

Jannis Kountouras et al. Surg Endosc. 2012 Jan.

. 2012 Jan;26(1):283-4.

doi: 10.1007/s00464-011-1864-1.

Authors

Jannis Kountouras, Dimitrios Chatzopoulos, Christos Zavos, Georgia Deretzi, Stergios A Polyzos, Emmanuel Gavalas, Philippos Klonizakis, Elizabeth Vardaka, Panagiotis Katsinelos, Christos Stergiopoulos, John Moschos, Evaggelia Giartza-Taxidou

PMID: 21858571
DOI: 10.1007/s00464-011-1864-1

No abstract available

PubMed Disclaimer

Comment on

Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies.
Lewis CJ, Thrumurthy SG, Pritchard S, Armstrong G, Attwood SE. Lewis CJ, et al. Surg Endosc. 2011 Aug;25(8):2564-9. doi: 10.1007/s00464-011-1587-3. Epub 2011 Feb 27. Surg Endosc. 2011. PMID: 21359892

Similar articles

Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First).
Thrumurthy SG, Lewis CJ, Pritchard S, Armstrong G, Attwood SE. Thrumurthy SG, et al. Surg Endosc. 2012 Jan;26(1):291-2. doi: 10.1007/s00464-011-1842-7. Surg Endosc. 2012. PMID: 21853395 No abstract available.
Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies.
Lewis CJ, Thrumurthy SG, Pritchard S, Armstrong G, Attwood SE. Lewis CJ, et al. Surg Endosc. 2011 Aug;25(8):2564-9. doi: 10.1007/s00464-011-1587-3. Epub 2011 Feb 27. Surg Endosc. 2011. PMID: 21359892
Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
Soslow RA, Remotti H, Baergen RN, Altorki NK. Soslow RA, et al. Mod Pathol. 1999 Mar;12(3):239-50. Mod Pathol. 1999. PMID: 10102608
The continuing tale of cytokeratins in Barrett's mucosa: as you like it.
Latchford A, Eksteen B, Jankowski J. Latchford A, et al. Gut. 2001 Dec;49(6):746-7. doi: 10.1136/gut.49.6.746. Gut. 2001. PMID: 11709501 Free PMC article. Review. No abstract available.
Biomarkers in Barrett's esophagus (review).
van Lieshout EM, Jansen JB, Peters WH. van Lieshout EM, et al. Int J Oncol. 1998 Oct;13(4):855-64. doi: 10.3892/ijo.13.4.855. Int J Oncol. 1998. PMID: 9735417 Review.

See all similar articles

References

1. Lancet. 2006 Sep 16;368(9540):986; author reply 986-7 - PubMed
1. J Surg Oncol. 2005 Dec 1;92(3):151-9 - PubMed
1. Lancet. 2001 Jun 2;357(9270):1738-42 - PubMed
1. Scand J Gastroenterol. 2004 Dec;39(12):1314 - PubMed
1. Med Hypotheses. 2007;68(5):1174-5 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program